S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)

Compare Stocks

Date Range: 

 IQVIACharles River Laboratories InternationalBitcoin GroupExact SciencesPPD
SymbolNYSE:IQVNYSE:CRLOTCMKTS:BTGGFNASDAQ:EXASNASDAQ:PPD
Price Information
Current Price$249.02$412.52$59.80$96.52$47.03
50-Day Moving Average$252.73$426.71$42.97$98.84$46.59
52-Week Low$150.65$219.79$25.63$89.65$31.54
52-Week High$265.34$460.21$69.50$159.54$47.08
MarketRank™
Overall Score2.02.10.92.51.9
Analysis Score2.52.40.04.41.1
Community Score4.74.34.35.04.7
Dividend Score0.00.00.00.00.0
Ownership Score1.72.50.02.51.7
Earnings & Valuation Score1.31.30.00.61.9
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyHold
Consensus Price Target$262.76$399.83N/A$148.25$44.93
% Upside from Price Target5.52% upside-3.08% downsideN/A53.60% upside-4.47% downside
Trade Information
Market Cap$47.72 billion$20.79 billion$23.11 billion$16.60 billion$16.52 billion
Beta1.431.140.261.292.22
Average Volume878,339417,1813981,523,6801,971,204
Sales & Book Value
Annual Revenue$11.36 billion$2.92 billionN/A$1.49 billion$4.68 billion
Price / Sales4.207.11N/A11.133.53
Cashflow$12.96 per share$12.15 per shareN/A$1.47 per share$2.00 per share
Price / Cash19.2233.96N/A65.7023.46
Book Value$32.76 per share$42.55 per shareN/A$18.77 per share($2.13) per share
Price / Book7.609.69N/A5.14-22.08
Profitability
Net Income$279 million$364.30 millionN/A$-848.53 million$153.69 million
EPS$6.03$8.13N/A($1.38)$1.13
Trailing P/E Ratio79.8153.160.00N/A65.32
Forward P/E Ratio26.4935.20N/A28.68
P/E Growth1.923.07N/AN/A2.32
Net Margins4.69%12.10%N/A-50.52%3.85%
Return on Equity (ROE)23.95%23.59%N/A-8.93%-53.95%
Return on Assets (ROA)6.03%8.66%N/A-4.86%6.08%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio2.111.17N/A0.53N/A
Current Ratio1.051.36N/A2.471.19
Quick Ratio1.051.15N/A2.341.19
Ownership Information
Institutional Ownership Percentage87.01%93.28%N/A88.31%87.87%
Insider Ownership Percentage1.10%1.20%N/A1.40%1.90%
Miscellaneous
Employees70,00018,400274,90026,000
Shares Outstanding191.61 million50.40 million386.49 million171.95 million351.32 million
Next Earnings Date10/21/2021 (Confirmed)11/3/2021 (Confirmed)N/A11/2/2021 (Confirmed)10/26/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableNot Optionable
SourceHeadline
Bioanalytical Services Market by Product, Applications, Geographic and Key Players: PPD, ICON, Algorithme – EcoChunk - EcoChunkBioanalytical Services Market by Product, Applications, Geographic and Key Players: PPD, ICON, Algorithme – EcoChunk - EcoChunk
ecochunk.com - October 19 at 3:59 PM
Man takes his own life in Pensacola Police Department parking lot - Pensacola News JournalMan takes his own life in Pensacola Police Department parking lot - Pensacola News Journal
pnj.com - October 19 at 3:59 PM
PPD Named Clinical Research Company of the Year for Second Consecutive Year - Business WirePPD Named Clinical Research Company of the Year for Second Consecutive Year - Business Wire
businesswire.com - October 19 at 3:59 PM
PPD (NASDAQ:PPD) Sees Large Volume IncreasePPD (NASDAQ:PPD) Sees Large Volume Increase
americanbankingnews.com - October 19 at 12:43 PM
PPD Named Clinical Research Company of the Year for Second Consecutive Year - Joplin GlobePPD Named Clinical Research Company of the Year for Second Consecutive Year - Joplin Globe
joplinglobe.com - October 19 at 10:05 AM
PPD Named Clinical Research Company of the Year for Second Consecutive YearPPD Named Clinical Research Company of the Year for Second Consecutive Year
finance.yahoo.com - October 19 at 10:05 AM
Six months in, PPD chief looks at his tenure - Appalachian News-ExpressSix months in, PPD chief looks at his tenure - Appalachian News-Express
news-expressky.com - October 19 at 5:04 AM
UPDATE: Standoff at Peoria home ends with no arrests or charges - HOI ABCUPDATE: Standoff at Peoria home ends with no arrests or charges - HOI ABC
hoiabc.com - October 19 at 5:04 AM
PPD Announces Third Quarter 2021 Earnings Conference Call | National Business | joplinglobe.com - Joplin GlobePPD Announces Third Quarter 2021 Earnings Conference Call | National Business | joplinglobe.com - Joplin Globe
joplinglobe.com - October 18 at 11:36 PM
PPD Announces Third Quarter 2021 Earnings Conference Call | Wire | chronicle-tribune.com - Chronicle-TribunePPD Announces Third Quarter 2021 Earnings Conference Call | Wire | chronicle-tribune.com - Chronicle-Tribune
chronicle-tribune.com - October 18 at 6:36 PM
PPD Announces Third Quarter 2021 Earnings Conference Call | News | bakersfield.com - The Bakersfield CalifornianPPD Announces Third Quarter 2021 Earnings Conference Call | News | bakersfield.com - The Bakersfield Californian
bakersfield.com - October 18 at 6:36 PM
PPD Announces Third Quarter 2021 Earnings Conference CallPPD Announces Third Quarter 2021 Earnings Conference Call
finance.yahoo.com - October 18 at 6:36 PM
Search planned on Wednesday for missing Plattsmouth man - KMTV - 3 News NowSearch planned on Wednesday for missing Plattsmouth man - KMTV - 3 News Now
3newsnow.com - October 18 at 1:35 PM
Bioanalytical Testing Services Market Global Analysis 2021-2028: Pace Analytical Services, PPD, Toxikon, Covance, Intertek group, and Many More. – Puck77 - Puck77Bioanalytical Testing Services Market Global Analysis 2021-2028: Pace Analytical Services, PPD, Toxikon, Covance, Intertek group, and Many More. – Puck77 - Puck77
puck77.com - October 18 at 8:34 AM
PPD hiring unarmed public safety officers - WHYYPPD hiring unarmed public safety officers - WHYY
whyy.org - October 18 at 8:34 AM
Northeast Ohio high school football scores for Friday, Oct. 15 - cleveland.comNortheast Ohio high school football scores for Friday, Oct. 15 - cleveland.com
cleveland.com - October 16 at 9:22 AM
UK Watchdog to Investigate Thermo Fishers Planned Acquisition of PPDUK Watchdog to Investigate Thermo Fisher's Planned Acquisition of PPD
morningstar.com - October 16 at 1:16 AM
UK Watchdog Probing Thermo Fishers $21B PPD DealUK Watchdog Probing Thermo Fisher's $21B PPD Deal
law360.com - October 16 at 1:16 AM
To improve equity on the road, Philly bans police stops for minor traffic infractions - WHYYTo improve equity on the road, Philly bans police stops for minor traffic infractions - WHYY
whyy.org - October 15 at 10:13 AM
Sheriff and PPD Find Drugs, Guns at Rosemount Hotel - Scioto County Daily NewsSheriff and PPD Find Drugs, Guns at Rosemount Hotel - Scioto County Daily News
sciotocountydailynews.com - October 15 at 10:13 AM
Thermo Fisher bid to acquire PPD comes under regulatory scrutiny in U.K. - Seeking AlphaThermo Fisher bid to acquire PPD comes under regulatory scrutiny in U.K. - Seeking Alpha
seekingalpha.com - October 15 at 10:13 AM
Jail Booking Report for October 5 - 12 - The Gila HeraldJail Booking Report for October 5 - 12 - The Gila Herald
gilaherald.com - October 14 at 7:28 PM
PPD selected for Dept. of Justice partnership in effort to combat violent crime - Metro USPPD selected for Dept. of Justice partnership in effort to combat violent crime - Metro US
philly.metro.us - October 13 at 7:27 PM
PPD: One person shot multiple times Tuesday in north Pensacola - Pensacola News JournalPPD: One person shot multiple times Tuesday in north Pensacola - Pensacola News Journal
pnj.com - October 13 at 2:26 PM
Why You Need PPD Inc. (PPD) On Your Watchlist - The Fosters LeaderWhy You Need PPD Inc. (PPD) On Your Watchlist - The Fosters Leader
fostersleader.com - October 13 at 2:26 PM
PPD (NASDAQ:PPD) Lifted to "Hold" at Zacks Investment ResearchPPD (NASDAQ:PPD) Lifted to "Hold" at Zacks Investment Research
marketbeat.com - September 25 at 2:31 AM
DateCompanyBrokerageAction
10/15/2021IQVIAKeyCorp
Boost Price Target
10/14/2021Charles River Laboratories InternationalEvercore ISI
Reiterated Rating
10/14/2021Exact SciencesCowen
Lower Price Target
9/10/2021IQVIAArgus
Boost Price Target
8/31/2021PPDDeutsche Bank Aktiengesellschaft
Upgrade
8/23/2021Charles River Laboratories InternationalArgus
Boost Price Target
8/17/2021Charles River Laboratories InternationalUBS Group
Boost Price Target
8/5/2021Charles River Laboratories InternationalCredit Suisse Group
Boost Price Target
8/5/2021Charles River Laboratories InternationalWells Fargo & Company
Boost Price Target
8/5/2021Charles River Laboratories InternationalRobert W. Baird
Boost Price Target
7/29/2021Exact SciencesStifel Nicolaus
Lower Price Target
7/29/2021Exact SciencesBTIG Research
Lower Price Target
7/29/2021Exact SciencesCanaccord Genuity
Lower Price Target
7/29/2021Exact SciencesOppenheimer
Lower Price Target
7/29/2021Exact SciencesRobert W. Baird
Lower Price Target
7/28/2021IQVIAMorgan Stanley
Boost Price Target
7/28/2021IQVIAMizuho
Boost Price Target
7/28/2021IQVIAPiper Sandler
Boost Price Target
7/28/2021IQVIADeutsche Bank Aktiengesellschaft
Boost Price Target
7/28/2021IQVIACitigroup
Boost Price Target
7/28/2021IQVIARobert W. Baird
Boost Price Target
7/20/2021IQVIACredit Suisse Group
Boost Price Target
7/20/2021Charles River Laboratories InternationalCredit Suisse Group
Boost Price Target
7/14/2021Exact SciencesSVB Leerink
Lower Price Target
7/13/2021IQVIABarclays
Boost Price Target
6/21/2021Exact SciencesWells Fargo & Company
Boost Price Target
6/15/2021Exact SciencesRaymond James
Initiated Coverage
6/3/2021Exact SciencesThe Goldman Sachs Group
Initiated Coverage
5/31/2021Charles River Laboratories InternationalRobert W. Baird
Reiterated Rating
5/28/2021Charles River Laboratories InternationalCredit Suisse Group
Boost Price Target
5/28/2021Charles River Laboratories InternationalJPMorgan Chase & Co.
Boost Price Target
5/28/2021Charles River Laboratories InternationalCitigroup
Boost Price Target
5/25/2021Charles River Laboratories InternationalTruist Securities
Boost Price Target
5/25/2021Exact SciencesWells Fargo & Company
Initiated Coverage
5/14/2021IQVIAKeyCorp
Boost Price Target
5/14/2021Charles River Laboratories InternationalKeyCorp
Boost Price Target
5/12/2021IQVIACanaccord Genuity
Boost Price Target
5/12/2021IQVIAArgus
Boost Price Target
5/12/2021Exact SciencesTruist
Lower Price Target
5/12/2021Exact SciencesTruist Securities
Lower Price Target
5/5/2021Charles River Laboratories InternationalDeutsche Bank Aktiengesellschaft
Boost Price Target
5/5/2021Charles River Laboratories InternationalRobert W. Baird
Boost Price Target
5/5/2021Exact SciencesCraig Hallum
Lower Price Target
5/5/2021Exact SciencesBTIG Research
Lower Price Target
5/5/2021Exact SciencesSVB Leerink
Lower Price Target
4/28/2021PPDJPMorgan Chase & Co.
Reiterated Rating
4/26/2021IQVIATruist
Boost Price Target
4/26/2021IQVIATruist Securities
Boost Price Target
4/26/2021IQVIAMorgan Stanley
Boost Price Target
4/26/2021IQVIABarclays
Boost Price Target
4/26/2021PPDCredit Suisse Group
Reiterated Rating
4/26/2021PPDJefferies Financial Group
Reiterated Rating
4/23/2021IQVIACitigroup
Boost Price Target
4/23/2021IQVIAJefferies Financial Group
Boost Price Target
4/23/2021IQVIARobert W. Baird
Boost Price Target
4/23/2021IQVIADeutsche Bank Aktiengesellschaft
Boost Price Target
4/23/2021IQVIAMizuho
Boost Price Target
4/22/2021PPDKeyCorp
Reiterated Rating
4/22/2021PPDWilliam Blair
Reiterated Rating
4/22/2021PPDDeutsche Bank Aktiengesellschaft
Reiterated Rating
4/21/2021PPDRobert W. Baird
Reiterated Rating
4/20/2021PPDJefferies Financial Group
Downgrade
4/19/2021PPDCitigroup
Downgrade
4/19/2021PPDMizuho
Downgrade
4/19/2021PPDCredit Suisse Group
Downgrade
4/16/2021IQVIAStephens
Upgrade
4/16/2021PPDTruist
Downgrade
4/16/2021PPDEvercore ISI
Downgrade
4/16/2021PPDTruist Securities
Reiterated Rating
4/16/2021PPDWilliam Blair
Downgrade
4/16/2021PPDDeutsche Bank Aktiengesellschaft
Downgrade
4/15/2021PPDRobert W. Baird
Downgrade
4/9/2021IQVIAMizuho
Boost Price Target
3/15/2021IQVIAKeyCorp
Upgrade
3/2/2021PPDBarclays
Initiated Coverage
2/25/2021Charles River Laboratories InternationalMorgan Stanley
Boost Price Target
2/25/2021PPDCitigroup
Boost Price Target
2/25/2021PPDDeutsche Bank Aktiengesellschaft
Boost Price Target
2/18/2021Charles River Laboratories InternationalTruist
Boost Price Target
2/18/2021Charles River Laboratories InternationalCredit Suisse Group
Boost Price Target
2/18/2021Charles River Laboratories InternationalDeutsche Bank Aktiengesellschaft
Boost Price Target
2/18/2021Exact SciencesRobert W. Baird
Lower Price Target
2/17/2021Exact SciencesStifel Nicolaus
Boost Price Target
2/17/2021Exact SciencesSVB Leerink
Boost Price Target
2/17/2021Exact SciencesCowen
Boost Price Target
1/27/2021Exact SciencesTruist
Initiated Coverage
1/21/2021Exact SciencesSVB Leerink
Boost Price Target
1/12/2021Exact SciencesCanaccord Genuity
Boost Price Target
12/22/2020Charles River Laboratories InternationalArgus
Boost Price Target
12/16/2020Charles River Laboratories InternationalSmith Barney Citigroup
Downgrade
11/24/2020Charles River Laboratories InternationalKeyCorp
Boost Price Target
11/3/2020Charles River Laboratories InternationalTruist
Boost Price Target
10/30/2020Charles River Laboratories InternationalMorgan Stanley
Boost Price Target
10/30/2020Charles River Laboratories InternationalDeutsche Bank Aktiengesellschaft
Boost Price Target
10/29/2020Exact SciencesUBS Group
Downgrade
10/29/2020PPDDeutsche Bank Aktiengesellschaft
Boost Price Target
10/28/2020Exact SciencesCanaccord Genuity
Boost Price Target
10/12/2020PPDTruist
Initiated Coverage
9/22/2020PPDMizuho
Boost Price Target
9/21/2020PPDRobert W. Baird
Boost Price Target
11/30/2018Bitcoin GroupJefferies Financial Group
Downgrade
11/26/2018Bitcoin GroupStifel Nicolaus
Reiterated Rating
(Data available from 10/19/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.